Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diagnosis of Early Gastric Cancer Aided by Optimal Band Imaging

By Biotechdaily staff writers
Posted on 10 Mar 2008
New research revealed that optimal band imaging used with an endoscope provided images that unmistakably identified depressed-type early gastric cancer without magnification in 96% of study participants. More...


Gastric cancer is one of the most prevalent types of cancer in the world. If gastric cancer is found early, the five-year survival rate increases nearly 90%. In contrast, most patients with advanced gastric cancer have a poor prognosis. Gastric cancer is classified as elevated, flat, and depressed types. In spite of improvements in endoscopic technologies, depressed-type early gastric cancer is challenging to diagnose because it manifests as slight alterations in color and shape. Variations in color, however, can also mean inflammation, so it is difficult to determine what is benign and what is malignant. Therefore, biopsies must then be taken.

"In our comparative study, the optimal band imaging system with endoscopy showed contrasting images that could delineate the depressed-type early gastric cancers more easily than conventional endoscopy,” said the study's lead author Hiroyuki Osawa, M.D., Jichi Medical University (Tochigi-Ken, Japan). "A distinct demarcation was observed endoscopically between the reddish images of the cancerous lesion and the yellowish images of the surrounding noncancerous area. This is the first report of optimal band images for early gastric cancer.”

Optimal band imaging (OBI) was developed with the goal of enhancing the capillary pattern and pit patterns of lesions in endoscopic images. In contrast to narrow band imaging, in which the bandwidth of spectral transmittance is narrowed by optical filters, the OBI system is based on a new spectral estimation technique that replaces the need for optical filters. OBI takes an ordinary endoscopic image from the video processor and arithmetically processes the reflected photons to reconstitute virtual images for a choice of different wavelengths.

An OBI system with electronic endoscope for the upper-gastrointestinal tract was used in this prospective study. Twenty-seven patients between May and December 2006 who were diagnosed with conventional endoscopy as having depressed-type early gastric cancer participated in the study. The mean age of the patients was 65.3 years with 23 men and 4 women. Twenty-four patients were diagnosed with differentiated adenocarcinoma and three patients with undifferentiated adenocarcinoma by the histopathologic evaluation of biopsy specimens. Researchers used the OBI system without magnification to observe the entire stomach because of the ample light intensity.

With the OBI system, depressed type-early gastric cancer in 26 of 27 cases were easily identified because it clearly showed contrasting demarcation lines between the reddish images of the cancerous lesions and the yellowish images of the surrounding noncancerous area. A 40-fold magnification was then applied to observe the pit pattern, the disappearance of pit pattern, or an irregular microvascular pattern of the cancerous lesions, which further enhanced the demarcation of the cancer and the noncancerous areas.

The researchers concluded that OBI images were better than traditional endoscopy images in identifying depressed-type early gastric cancer, but said that additional study is needed. They noted that even medical students, who had not had considerable amounts of clinical endoscopic experience, were able to easily identify the demarcation line between cancer and noncancerous areas in optimal band images versus conventional endoscopic images. OBI is available even without magnification during routine endoscopy because the system provides the same light intensity as conventional endoscopy. The researchers reported that such nonmagnified optimal band images might be ideal for screening, whereas magnified optimal band images are more suitable for detailed examination of early gastric cancer.

Endoscopy is performed by specially trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract. Using flexible, thin tubes called endoscopes, endoscopists are able to access the human digestive tract without incisions via natural orifices. Endoscopes are designed with high-intensity lighting and fitted with precision devices that allow viewing and treatment of the gastrointestinal system. In many cases, screening or treatment of conditions can be delivered via the endoscope without the need for further sedation, treatment or hospital stay.

The study was published in the February 2008 issue of Gastrointestinal Endoscopy.


Related Links:
Jichi Medical University

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.